Cite
HARVARD Citation
Seban, R. et al. (2019). Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy. Oncoimmunology. p. . [Online].